Integrity and Accountability—The Declining State of Physician Health and the Urgent Need for Ethical and Evidence-Based Leadership. Good leadership requires correct moral and ethical behavior…
15 thoughts on “Integrity and Accountability—The Declining State of Physician Health and the Urgent Need for Ethical and Evidence-Based Leadership”
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLiked by 1 person
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLiked by 1 person
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLiked by 1 person
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLiked by 1 person
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike
[…] In June of 2011 I signed a patent-license agreement with a company to bring an epinephrine auto-injector to FDA approval within three years. It was recently mentioned in an NBC news article in the wake of Mylan’s Epipen price hike and the patent documents can be seen here and a slideshare overview here. This was successfully derailed the following month when I was asked by the state PHP to have an alcohol test. This was for no apparent reason. I have never been accused of having an alcohol problem and my work performance at MGH was reported as “impeccable.” There were no issues in any arena. The events are described in detail here, here, and here. […]
LikeLike